This Government Contract opportunity from Department Of Agriculture was posted on August 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Olink Reveal reagents - sole source
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The United States Department of Agriculture's Agricultural Research Service requires Olink Reveal reagents to conduct quantitative analysis of protein biomarkers in plasma and serum samples for ongoing clinical studies. These reagents are essential for use with the Olink Signature Q100 system and utilize Proximity Extension Assay technology to analyze approximately 1,000 protein targets across 88 samples. The procurement is intended to be a sole source award to Olink Proteomics, a part of Thermo Fisher Scientific, as they are the registered trademark holder and sole distributor of these non-interchangeable reagents. This acquisition is being conducted under Simplified Acquisition Procedures in accordance with FAR Part 8.405-6(a)(1)(B), with an estimated value of 149,000 dollars for fiscal year 2026. The place of performance is located in College Station, Texas. While this is a notice of intent to award a sole source contract rather than a competitive solicitation, interested parties were given until August 31, 2026, to provide evidence that competition would be advantageous to the government.
General Info
Place of Performance
College Station, TX, 77843, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
USDA – ARS – RAFSRU requires Olink Reveal reagents compatible with the Olink Proximity Extension Assay (PEA) to conduct analysis of protein biomarkers to continue ongoing studies. The reagents are required to carry out quantitative analysis of protein levels in plasma and serum samples from clinical studies. The levels of specific biomarkers will be measured using the Olink Reveal Assay. Olink’s Proximity Extension Assay (PEA) technology combines specificity and scalability to enable high-throughput, multiplex protein biomarker analysis. (SEE ATTACHED NOTICE AND J&A)
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
